CME Group (NASDAQ:CME) Price Target Lowered to $285.00 at UBS Group

Key Points

• UBS Group lowered its price target for CME Group from $305.00 to $285.00, maintaining a "neutral" rating, which indicates a potential upside of 8.80% from the current price.
• Analysts have mixed opinions on CME Group, with ratings ranging from "buy" to "sell," culminating in an average rating of "hold" and an average target price of $260.60.
• In the last earnings report, CME Group exceeded expectations with an EPS of $2.96 on revenue of $1.69 billion, representing a 10.4% year-over-year revenue increase.

CME Group (NASDAQ:CME - Get Free Report) had its target price cut by stock analysts at UBS Group from $305.00 to $285.00 in a note issued to investors on Monday,Benzinga reports. The brokerage presently has a "neutral" rating on the financial services provider's stock. UBS Group's price target points to a potential upside of 8.80% from the company's current price.

A number of other analysts have also weighed in on the stock. Oppenheimer upped their target price on shares of CME Group from $300.00 to $303.00 and gave the stock an "outperform" rating in a report on Thursday, July 24th. Wall Street Zen cut shares of CME Group from a "hold" rating to a "sell" rating in a report on Sunday, July 13th. Citigroup upped their target price on CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a report on Thursday, July 3rd. Piper Sandler lifted their price target on CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a research report on Tuesday, July 15th. Finally, Erste Group Bank lowered shares of CME Group from a "strong-buy" rating to a "hold" rating in a research report on Saturday, May 24th. Four equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the company. According to MarketBeat.com, CME Group has an average rating of "Hold" and an average target price of $260.60.

CME Group Trading Down 2.1%

Shares of CME Group stock opened at $261.94 on Monday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. The company has a market capitalization of $94.40 billion, a price-to-earnings ratio of 25.36, a PEG ratio of 4.74 and a beta of 0.43. The firm's 50-day moving average price is $274.96 and its two-hundred day moving average price is $270.15. CME Group has a 12-month low of $212.38 and a 12-month high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last announced its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, topping the consensus estimate of $2.91 by $0.05. The firm had revenue of $1.69 billion for the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The business's quarterly revenue was up 10.4% compared to the same quarter last year. During the same period in the previous year, the business earned $2.56 EPS. On average, analysts forecast that CME Group will post 10.49 earnings per share for the current fiscal year.

Insider Buying and Selling at CME Group

In related news, insider Sunil Cutinho sold 11,896 shares of CME Group stock in a transaction on Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total value of $3,229,407.12. Following the transaction, the insider owned 17,440 shares in the company, valued at approximately $4,734,436.80. This trade represents a 40.55% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director William R. Shepard bought 256 shares of the firm's stock in a transaction dated Wednesday, June 25th. The stock was purchased at an average price of $270.53 per share, with a total value of $69,255.68. Following the transaction, the director owned 258,196 shares in the company, valued at approximately $69,849,763.88. This represents a 0.10% increase in their position. The disclosure for this purchase can be found here. Insiders own 0.30% of the company's stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the company. Webster Bank N. A. lifted its stake in shares of CME Group by 206.9% during the 2nd quarter. Webster Bank N. A. now owns 89 shares of the financial services provider's stock valued at $25,000 after buying an additional 60 shares in the last quarter. Highline Wealth Partners LLC grew its stake in shares of CME Group by 84.3% in the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider's stock worth $26,000 after purchasing an additional 43 shares during the last quarter. Wayfinding Financial LLC purchased a new position in shares of CME Group during the first quarter valued at about $25,000. Cornerstone Planning Group LLC boosted its stake in CME Group by 122.2% during the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock worth $26,000 after acquiring an additional 55 shares in the last quarter. Finally, Sagard Holdings Management Inc. purchased a new stake in CME Group during the 2nd quarter valued at about $30,000. Institutional investors and hedge funds own 87.75% of the company's stock.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.